Breaking News Instant updates and real-time market news.

NKE

Nike

$75.22

0.14 (0.19%)

, KO

Coca-Cola

$49.86

-0.01 (-0.02%)

17:49
11/13/18
11/13
17:49
11/13/18
17:49

Nike names former Coca-Cola exec Williams president of Jordan Brand

Nike (NKE) announced that effective Jan. 14, 2019, Craig A. Williams will become President of Jordan Brand. Williams joins Jordan Brand from The Coca-Cola Co. (KO), where he most recently served as Senior Vice President, The Coca-Cola Co. and President of The McDonald's Division Worldwide and was responsible for growing brands and beverages categories. Larry Miller, current Jordan Brand President, will become Chairman for the newly created Jordan Brand Advisory Board.

NKE

Nike

$75.22

0.14 (0.19%)

KO

Coca-Cola

$49.86

-0.01 (-0.02%)

  • 13

    Nov

  • 03

    Mar

NKE Nike
$75.22

0.14 (0.19%)

10/18/18
10/18/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Nike (NKE) upgraded to Outperform from Perform at Oppenheimer with analyst Brian Nagel saying Nike represents an "already dominant, legacy global brand that is now aggressively embracing the power of digital to enhance most facets of its business." 2. United Continental (UAL) upgraded to Outperform from Neutral at Macquarie and to Overweight from Equal Weight at Stephens. 3. Generac (GNRC) upgraded to Neutral from Sell at Goldman Sachs with analyst Jerry Revich saying the company's organic growth outlook is improving amid rising power disturbances. 4. Proteostasis (PTI) upgraded to Outperform from Sector Perform at RBC Capital with analyst Brian Abrahams citing an "impressive" set of data from its phase 2 cystic fibrosis doublet trial. 5. Safe Bulkers (SB) upgraded to Outperform from In Line at Evercore ISI with analyst Jonathan Chappell saying the disconnect between dry bulk equity prices and spot rates continues to widen due to global trade/macro fears. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/22/18
OPCO
10/22/18
NO CHANGE
OPCO
Outperform
Nike well positioned to weather potential tariffs, says Oppenheimer
Oppenheimer analyst Brian Nagel argues that while the dynamic surrounding potential, incremental tariffs on Chinese-manufactured items imported to the U.S. is fluid, Nike is quite well insulated to this threat. Per his math, footwear and apparel manufactured in China and sold in the U.S. represent just 10%-15% of total production in these categories for Nike, and the company already operates manufacturing facilities elsewhere in Asia and could further shift production out of China, over time, if necessary. Further, Nagel points out that management indicates that given the complexity of the overall Nike manufacturing and sourcing operations, the company has many levers to pull in order to help offset impacts of potential incremental import costs. Athletic footwear and apparel manufactured in China are already subject to duties at a mid-teens rate, while the company is enjoying significant pricing power with consumers, he adds. The analyst reiterates an Outperform rating on the shares.
10/27/18
GSCO
10/27/18
DOWNGRADE
GSCO
Neutral
Flex downgraded to Neutral from Buy at Goldman Sachs
Goldman Sachs analyst Mark Delaney downgraded Flex (FLEX) to Neutral following the company's Q2 results and announcement of a CEO change and wind down of its footwear manufacturing operations with Nike (NKE) in Mexico. While Flex's current valuation is "very inexpensive," the CEO transition and "consumer disengagement" could provide an overhang for several quarters, Delaney tells investors in a research note. Flex closed Friday down 35%, or $3.82, to $7.09.
10/30/18
ARGS
10/30/18
DOWNGRADE
ARGS
Flex downgraded to Hold from Buy at Argus
Argus analyst Jim Kelleher downgraded Flex (FLEX) to Hold after its "disappointing" Q2 results and "weak" Q3 guidance revealed last week. The analyst also cites the expected impact from the "shutdown of Mexican operations with key customer Nike (NKE), which he expects to be fully unwound", as well as the retirement of the company CEO Mike McNamara who had presided over the company's business expansion. Kelleher adds that the loss of Nike compounds lost business from other high-profile clients, including toymaker Lego as well as numerous mobile device makers.
KO Coca-Cola
$49.86

-0.01 (-0.02%)

11/08/18
SUSQ
11/08/18
NO CHANGE
Target $46
SUSQ
Negative
Monster Beverage results solid, but Coke conflict an overhang, says Susquehanna
Susquehanna analyst Pablo Zuanic said Monster Beverage (MNST) reported solid Q3 earnings, though gross margins missed again. However, he thinks a price hike effective on November 1 should mitigate the gross margin pressure. He believes a budding conflict with Coca-Cola (KO) could call into question the company's ability to grow and will be an overhang on the stock. Zuanic reiterated his Negative rating, though he raised his price target to $46 from $44 on Monster Beverage shares.
11/09/18
SBSH
11/09/18
NO CHANGE
Target $56
SBSH
Buy
Coca-Cola should trade at a 50% premium to market, says Citi
After spending time in Europe with CEO James Quincey, Citi analyst Wendy Nicholson says her confidence in Coca-Cola "continues to go up." Given her confidence in the company's ability to deliver on its growth targets, she continues to believe the stock should trade at a 50% premium to the market. The analyst raised her price target for Coca-Cola shares to $56 from $54 and keeps a Buy rating on the name.
11/09/18
BMOC
11/09/18
NO CHANGE
Target $60
BMOC
Outperform
Monster Beverage price target lowered to $60 from $70 at BMO Capital
BMO Capital analyst Amit Sharma lowered his price target on Monster Beverage (MNST) to $60 to reflect its selloff yesterday on reported possibility of Coca-Cola (KO) entering the energy drink category. The analyst notes however that while the threat may pose a near-term overhang on the stock, the impact on its growth and valuation is likely overblown. Sharma cites the "deep economic alignment" between the two companies and their bottlers, along with the company's willingness to find an acceptable resolution. The analyst also keeps his Outperform rating on Monster Beverage.
11/09/18
GSCO
11/09/18
UPGRADE
Target $66
GSCO
Conviction Buy
Monster Beverage upgraded to Conviction Buy from Buy at Goldman Sachs
Goldman analyst Judy Hong added Monster Beverage to the Conviction Buy List saying concerns over the dispute Coca-Cola (KO) are overdone and recommends buying shares on weakness. Hong believes Monster's shares downside is limited from a Coca-Cola Energy launch and does not believe the partnership is in jeopardy. The analyst sees upside to consensus 2019/20 estimates and a path to her $66 price target based on mid-teens plus earnings growth.

TODAY'S FREE FLY STORIES

SCRYY

Scor

$0.00

(0.00%)

07:53
04/23/19
04/23
07:53
04/23/19
07:53
Conference/Events
Scor management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

07:53
04/23/19
04/23
07:53
04/23/19
07:53
Conference/Events
The Board of Governors of the Federal Reserve System to hold a meeting »

The Board of Governors of…

AUTL

Autolus Therapeutics

$26.67

0.09 (0.34%)

07:52
04/23/19
04/23
07:52
04/23/19
07:52
Hot Stocks
Autolus Therapeutics receives orphan drug designation for enriched T-cells »

Autolus Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

MDSO

Medidata

$90.30

11.44 (14.51%)

, DASTY

Dassault Systemes

$0.00

(0.00%)

07:52
04/23/19
04/23
07:52
04/23/19
07:52
Downgrade
Medidata, Dassault Systemes rating change  »

Medidata downgraded to…

MDSO

Medidata

$90.30

11.44 (14.51%)

DASTY

Dassault Systemes

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 30

    Apr

  • 23

    Jun

AZRX

AzurRx BioPharma

$2.60

0.185 (7.68%)

07:50
04/23/19
04/23
07:50
04/23/19
07:50
Hot Stocks
AzurRx BioPharma surpasses 50% enrollment for Phase 2 OPTION study »

AzurRx BioPharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

HAL

Halliburton

$31.09

-0.03 (-0.10%)

07:50
04/23/19
04/23
07:50
04/23/19
07:50
Recommendations
Halliburton analyst commentary at SunTrust »

Halliburton price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 15

    May

  • 22

    May

  • 29

    May

  • 13

    Nov

JBLU

JetBlue

$16.84

-0.13 (-0.77%)

07:50
04/23/19
04/23
07:50
04/23/19
07:50
Hot Stocks
JetBlue sees Q2 effective tax rate of approx. 25% »

JetBlue expects an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 16

    May

  • 12

    Jun

ACHC

Acadia

$29.66

0.16 (0.54%)

07:49
04/23/19
04/23
07:49
04/23/19
07:49
Recommendations
Acadia analyst commentary  »

Citi opens 'Positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 02

    May

PAG

Penske Automotive

$44.64

-1.305 (-2.84%)

07:48
04/23/19
04/23
07:48
04/23/19
07:48
Conference/Events
Penske Automotive management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 09

    May

  • 14

    May

  • 15

    May

  • 28

    May

  • 29

    May

  • 03

    Jun

  • 11

    Jun

  • 12

    Jun

  • 13

    Nov

JBLU

JetBlue

$16.84

-0.13 (-0.77%)

07:47
04/23/19
04/23
07:47
04/23/19
07:47
Hot Stocks
JetBlue says 'on track' to hit 2018-2020 CASM CAGR goal of 0-1% growth »

Says executing on plan to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 16

    May

  • 12

    Jun

JEC

Jacobs Engineering

$78.69

1.755 (2.28%)

07:47
04/23/19
04/23
07:47
04/23/19
07:47
Hot Stocks
Jacobs Engineering extends contract with Watercare »

Jacobs has secured a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

PRIM

Primoris

$22.00

0.14 (0.64%)

07:47
04/23/19
04/23
07:47
04/23/19
07:47
Hot Stocks
Primoris announces natural gas distribution awards with value over $25M »

Primoris announced three…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 07

    May

PACW

PacWest Bancorp

$38.85

-0.39 (-0.99%)

07:47
04/23/19
04/23
07:47
04/23/19
07:47
Conference/Events
PacWest Bancorp management to meet with JMP Securities »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 13

    May

ISRG

Intuitive Surgical

$490.70

-37.34 (-7.07%)

07:46
04/23/19
04/23
07:46
04/23/19
07:46
Recommendations
Intuitive Surgical analyst commentary at Citi »

Intuitive Surgical price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 03

    May

NVR

NVR

$3,260.82

173.72 (5.63%)

07:45
04/23/19
04/23
07:45
04/23/19
07:45
Recommendations
NVR analyst commentary  »

NVR price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

LMT

Lockheed Martin

$315.24

0.94 (0.30%)

07:45
04/23/19
04/23
07:45
04/23/19
07:45
Hot Stocks
Breaking Hot Stocks news story on Lockheed Martin »

Lockheed Martin up 6% to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 25

    Apr

  • 29

    May

  • 05

    Jun

CVE

Cenovus Energy

$10.43

0.345 (3.42%)

07:45
04/23/19
04/23
07:45
04/23/19
07:45
Recommendations
Cenovus Energy analyst commentary at Citi »

Citi opens '30-Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

NUE

Nucor

$57.00

-0.495 (-0.86%)

07:43
04/23/19
04/23
07:43
04/23/19
07:43
Hot Stocks
Nucor CEO says 'well-positioned for continued growth and success' »

"Our diversified…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 09

    May

ZTO

ZTO Express

$19.30

-0.3 (-1.53%)

07:43
04/23/19
04/23
07:43
04/23/19
07:43
Upgrade
ZTO Express rating change  »

ZTO Express upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

DLR

Digital Realty

$119.37

-1.06 (-0.88%)

07:43
04/23/19
04/23
07:43
04/23/19
07:43
Downgrade
Digital Realty rating change at Jefferies »

Jefferies downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 13

    May

  • 04

    Jun

  • 18

    Jun

WSO

Watsco

$150.99

-0.39 (-0.26%)

07:42
04/23/19
04/23
07:42
04/23/19
07:42
Earnings
Watsco reports Q1 EPS 88c, consensus 88c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 30

    Apr

  • 05

    Jun

  • 05

    Jun

  • 13

    Nov

TWTR

Twitter

$34.39

-0.01 (-0.03%)

07:42
04/23/19
04/23
07:42
04/23/19
07:42
Hot Stocks
Twitter sees FY19 CapEx $550M-$600M »

Sees GAAP operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 20

    May

STAG

STAG Industrial

$28.47

-0.405 (-1.40%)

07:42
04/23/19
04/23
07:42
04/23/19
07:42
Initiation
STAG Industrial initiated  »

STAG Industrial initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Apr

  • 01

    May

FCPT

Four Corners Property Trust

$27.75

-0.42 (-1.49%)

07:41
04/23/19
04/23
07:41
04/23/19
07:41
Initiation
Four Corners Property Trust initiated  »

Four Corners Property…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

HBCP

Home Bancorp

$36.30

-0.67 (-1.81%)

07:41
04/23/19
04/23
07:41
04/23/19
07:41
Hot Stocks
Home Bancorp raises dividend 5% to 21c »

The Company increased its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.